Delivery Order 36F79725D0234-36C26126N0271
Award Date 1/2/26
Potential Completion Date 2/28/26
Potential Value $23K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Horsham, PA 19044, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Janssen Products LP, a subsidiary of Johnson & Johnson, to provide the antitubercular drug Sirturo (bedaquiline) to VA medical facilities. The $22,685.43 award is part of Janssen's indefinite delivery vehicle under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple award contract potentially worth $881 million. The VA has also awarded...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $22,685 delivery order to Janssen Products LP under the company's Pharmaceuticals and Drugs GSA Schedule. The firm fixed price order is to provide bedaquiline sirturo, an antitubercular drug, for use in VHA's tuberculosis treatment programs. Performance will take place at Janssen's facility in Horsham, Pennsylvania over a two month period from November 2023 through January 2024....
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $22,685 delivery order contract to Janssen Products LP under its Pharmaceuticals and Drugs GSA Schedule. The contract calls for Janssen to provide Sirturo to the VA to treat multidrug-resistant tuberculosis. The single award is a firm fixed price order to be performed in Horsham, Pennsylvania over a period of two months from December 2023 through February 2024. No subcontractors...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a $22,685 delivery order against the Janssen Products LP Pharmaceuticals and Drugs GSA Schedule to provide Sirturo 100mg tablets. As part of its mission to provide healthcare services to veterans, VA-VHA VISN 21 issued this order for the antituberculosis medication to likely treat patients within its region. Janssen will deliver the product to a facility in Horsham, Pennsylvania...
- Janssen Products LP, doing business as Ortho Biotech Products, LP, was awarded a $22,685.43 firm fixed price delivery order against the Pharmaceuticals and Drugs (FSS-61-IB) master contract vehicle. The order calls for Janssen to provide SIRTURO to the Veterans Health Administration Veterans Integrated Service Network 21, located in Horsham, Pennsylvania, with performance at that same location. No set-aside designation was used for this award to support the Veterans Affairs' mission of providing...
- Janssen Products LP has been awarded a $22,685.43 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) master contract to provide SIRTURO 100MG tablets to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. The delivery order has a completion date of May 26, 2023 and was awarded on March 27, 2023. It utilizes a firm fixed price contracting method and will be performed in Horsham, Pennsylvania. No...
- Janssen Products LP, doing business as Ortho Biotech Products, LP, has been awarded a $22,685.43 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21. To be performed in Horsham, Pennsylvania through March 2024, this order is for the provision of Sirturo to support the VA network's treatment programs. No set-aside designation was applied to this...
- This federal contract award to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., is for the supply of PHARMACY DRUGS, specifically oncology medications and other specialty drugs, to the U.S. Department of Veterans Affairs (VA). The $356,183.07 ceiling value contract was awarded on October 1, 2023 and has an ultimate completion date of September 30, 2024. This contract is a Delivery Order issued under Janssen Biotech's $3.1 billion multiple-award Federal Supply Schedule (FSS)...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a firm fixed price delivery order to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., for the chemotherapy drug BALVERSA (erdafitinib). This order was placed against Janssen's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, a $3.1 billion multiple award schedule that allows VHA to procure prescription drugs to support veteran healthcare programs. The $22,053.66...
- This federal contract award is a firm fixed price delivery order issued by the Department of Veterans Affairs (VA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., a pharmaceutical manufacturer. The $18,803.91 contract is for the delivery of BALVERSA 4 MG, an oncology medication, to support healthcare services for veterans. The contract has no set-aside designation and is issued against the VA's Federal Supply Schedule (FSS-61-IB) for Pharmaceuticals and Drugs, which is...